Ui-Soon Khoo Selected Research

reparixin

1/2022

Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ui-Soon Khoo Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 10/2023 - 08/2010
14	Neoplasms (Cancer) 12/2022 - 04/2002
5	Neoplasm Metastasis (Metastasis) 04/2023 - 09/2011
5	Infections 07/2010 - 01/2006
3	Endometrial Neoplasms (Endometrial Cancer) 07/2008 - 02/2005
2	Severe Acute Respiratory Syndrome 07/2010 - 07/2007
2	Ovarian Neoplasms (Ovarian Cancer) 04/2005 - 07/2002
1	Triple Negative Breast Neoplasms 11/2021
1	Hypoxia (Hypoxemia) 09/2011
1	Esophageal Squamous Cell Carcinoma 08/2011
1	Carcinogenesis 07/2008
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2007
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2005
1	Hydatidiform Mole (Molar Pregnancy) 01/2005
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2004
1	Adenocarcinoma 03/2004
1	Triploidy 01/2004
1	Carcinoma (Carcinomatosis) 07/2002

Drug/Important Bio-Agent (IBA)

11	Tamoxifen FDA LinkGeneric 04/2023 - 08/2010
7	Estrogen ReceptorsIBA 02/2022 - 01/2012
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2005
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
3	Co-Repressor ProteinsIBA 10/2023 - 01/2013
3	Messenger RNA (mRNA)IBA 07/2008 - 07/2002
3	DNA (Deoxyribonucleic Acid)IBA 07/2008 - 04/2002
2	CarcinogensIBA 12/2022 - 01/2022
2	Androgen Receptors (Androgen Receptor)IBA 12/2022 - 01/2022
2	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 07/2010 - 08/2008
2	Glutathione Transferase (Glutathione S-Transferase)IBA 04/2005 - 02/2005
1	Aromatase InhibitorsIBA 10/2023
1	Anastrozole (Arimidex)FDA LinkGeneric 10/2023
1	bicalutamide (Casodex)FDA LinkGeneric 10/2023
1	Therapeutic UsesIBA 10/2023
1	Estrogen Receptor alphaIBA 12/2022
1	SteroidsIBA 12/2022
1	Hormones (Hormone)IBA 12/2022
1	Checkpoint Kinase 2IBA 10/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	reparixinIBA 01/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	IvabradineIBA 11/2021
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 11/2021
1	Eukaryotic Initiation Factor-4EIBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	EpitopesIBA 01/2018
1	Minichromosome Maintenance ProteinsIBA 01/2015
1	Epirubicin (Ellence)FDA LinkGeneric 07/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	CollagenIBA 09/2011
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 09/2011
1	Hypoxia-Inducible Factor 1IBA 09/2011
1	Transcription Factors (Transcription Factor)IBA 08/2011
1	Proto-Oncogene Proteins c-etsIBA 05/2011
1	transcription factor PEA3IBA 05/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2010
1	Interferon-betaIBA 06/2010
1	Decitabine FDA Link 07/2008
1	MethyltransferasesIBA 07/2008
1	Cell Adhesion MoleculesIBA 07/2007
1	Intercellular Adhesion Molecule-3IBA 07/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2006
1	valylvaline (Val-Val)IBA 04/2005
1	Valine (L-Valine)FDA Link 04/2005
1	ParaffinIBA 04/2004
1	Formaldehyde (Formol)FDA Link 04/2004
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 03/2004
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2004
1	Ki-67 Antigen (Ki 67 Antigen)IBA 03/2004
1	Hematoxylin (Haematoxylon)IBA 03/2004
1	Complement System Proteins (Complement)IBA 01/2004

Therapy/Procedure

5	Therapeutics 10/2023 - 03/2021
2	Drug Therapy (Chemotherapy) 08/2010 - 01/2005
1	Neoadjuvant Therapy 01/2022
1	Transplantation 09/2011
1	Aftercare (After-Treatment) 07/2008